Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 29%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is positioned for continued success with its strong performance in key segments, advancements in technology, and projected revenue growth. The company's diverse geographic presence and recurring revenue streams add stability to its financials, and its strong correlation between revenue and backlog growth serves as evidence of its continued potential for growth. The recent creation of a new segment and projected organic growth and margin increase further support a positive outlook for GE HealthCare Techs.

Bears say

GE HealthCare Techs is a leading medical technology firm with a diverse portfolio of products and a strong market presence. However, the company's recent financials have been mixed, with declining EBIT margins and lower-than-expected revenue growth. This, coupled with potential challenges in key markets and supply chain disruptions, leads to a negative outlook on the stock. Despite potential upside from new product introductions and M&A, the overall risks and uncertainties for GE HealthCare Techs make it a risky investment at this time.

GEHC has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 29% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 14 analysts, GEHC has a Buy consensus rating as of May 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.